University of Florida researchers found an association between glucosamine supplementation and increased progression from mild cognitive impairment to Alzheimer's disease, with a 25% higher likelihood of progression and increased mortality risk in dementia patients. The study, published in Nature Metabolism, suggests metabolic dysfunction involving protein sugar-tagging pathways may contribute to Alzheimer's progression.
Topicle Beta
1 comment
University of Florida researchers found an association between glucosamine supplementation and increased progression from mild cognitive impairment to Alzheimer's disease, with a 25% higher likelihood of progression and increased mortality risk in dementia patients. The study, published in Nature Metabolism, suggests metabolic dysfunction involving protein sugar-tagging pathways may contribute to Alzheimer's progression.